Literature DB >> 19757026

Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant.

Aileen F G Bongat1, Rina Saksena, Roberto Adamo, Yukari Fujimoto, Zenyu Shiokawa, Dwight C Peterson, Koichi Fukase, Willie F Vann, Pavol Kovác.   

Abstract

Using recombinant tetanus toxin H(C) fragment (rTT-H(C)) as carrier, we prepared multimeric bivalent immunogens featuring the synthetic hexasaccharide fragment of O-PS of Vibrio cholerae O:1, serotype Ogawa, in combination with either the synthetic hexasaccharide fragment of O-PS of Vibrio cholerae O:1, serotype Inaba, or a synthetic disaccharide tetrapeptide peptidoglycan fragment as adjuvant. The conjugation reaction was effected by squaric acid chemistry and monitored in virtually real time by SELDI-TOF MS. In this way, we could prepare well-defined immunogens with predictable carbohydrate-carrier ratio, whose molecular mass and the amount of each saccharide attached could be independently determined. The ability to prepare such neoglycoconjugates opens unprecedented possibilities for preparation of conjugate vaccines for bacterial diseases from synthetic carbohydrates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757026     DOI: 10.1007/s10719-009-9259-4

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  37 in total

1.  Conjugating low molecular mass carbohydrates to proteins. 1. Monitoring the progress of conjugation.

Authors:  Rina Saksena; Anatoly Chernyak; Alex Karavanov; Pavol Kovác
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

Review 2.  Intracellular NOD-like receptors in host defense and disease.

Authors:  Thirumala-Devi Kanneganti; Mohamed Lamkanfi; Gabriel Núñez
Journal:  Immunity       Date:  2007-10       Impact factor: 31.745

3.  Glycoconjugate vaccines.

Authors:  N Ravenscroft; C Jones
Journal:  Curr Opin Drug Discov Devel       Date:  2000-03

4.  Identification of a binding site for ganglioside on the receptor binding domain of tetanus toxin.

Authors:  Heather A Louch; Ellen S Buczko; Mary A Woody; Richard M Venable; Willie F Vann
Journal:  Biochemistry       Date:  2002-11-19       Impact factor: 3.162

5.  The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding.

Authors:  P Emsley; C Fotinou; I Black; N F Fairweather; I G Charles; C Watts; E Hewitt; N W Isaacs
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 6.  Vaccines based on the cell surface carbohydrates of pathogenic bacteria.

Authors:  Christopher Jones
Journal:  An Acad Bras Cienc       Date:  2005-05-09       Impact factor: 1.753

7.  Mitogenic effects of bacterial cell walls and their components on murine splenocytes.

Authors:  H Takada; S Nagao; S Kotani; S Kawata; K Yokogawa; S Kusumoto; T Shiba; I Yano
Journal:  Biken J       Date:  1980-06

8.  One-pot preparation of a series of glycoconjugates with predetermined antigen-carrier ratio from oligosaccharides that mimic the O-PS of Vibrio cholerae O:1, serotype Ogawa.

Authors:  Rina Saksena; Xingquan Ma; Pavol Kovác
Journal:  Carbohydr Res       Date:  2003-11-14       Impact factor: 2.104

9.  Cloning, nucleotide sequencing, and expression of tetanus toxin fragment C in Escherichia coli.

Authors:  N F Fairweather; V A Lyness; D J Pickard; G Allen; R O Thomson
Journal:  J Bacteriol       Date:  1986-01       Impact factor: 3.490

10.  Neoglycoconjugates from synthetic tetra- and hexasaccharides that mimic the terminus of the O-PS of Vibrio cholerae O:1, serotype Inaba.

Authors:  Xingquan Ma; Rina Saksena; Anatoly Chernyak; Pavol Kovác
Journal:  Org Biomol Chem       Date:  2003-03-07       Impact factor: 3.876

View more
  11 in total

1.  Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look.

Authors:  Peng Xu; Meagan Kelly; Willie F Vann; Firdausi Qadri; Edward T Ryan; Pavol Kováč
Journal:  Chembiochem       Date:  2017-03-23       Impact factor: 3.164

2.  Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease.

Authors:  Roberto Adamo; Alberto Nilo; Carole Harfouche; Barbara Brogioni; Simone Pecetta; Giulia Brogioni; Evita Balducci; Vittoria Pinto; Sara Filippini; Elena Mori; Marta Tontini; Maria Rosaria Romano; Paolo Costantino; Francesco Berti
Journal:  Glycoconj J       Date:  2014-09-26       Impact factor: 2.916

Review 3.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

4.  Application of protein typing in molecular epidemiological investigation of nosocomial infection outbreak of aminoglycoside-resistant Pseudomonas aeruginosa.

Authors:  Min Song; Min Tang; Yinghuan Ding; Zecai Wu; Chengyu Xiang; Kui Yang; Zhang Zhang; Baolin Li; Zhenghua Deng; Jinbo Liu
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-16       Impact factor: 4.223

5.  Conjugation of carbohydrates to proteins using di(triethylene glycol monomethyl ether) squaric acid ester revisited.

Authors:  Peng Xu; Michael N Trinh; Pavol Kováč
Journal:  Carbohydr Res       Date:  2017-11-07       Impact factor: 2.104

6.  Mapping the glycation sites in the neoglycoconjugate from hexasaccharide antigen of Vibrio cholerae, serotype Ogawa and the recombinant tetanus toxin C-fragment carrier.

Authors:  Farid Jahouh; Peng Xu; Willie F Vann; Pavol Kováč; Joseph H Banoub
Journal:  J Mass Spectrom       Date:  2013-10       Impact factor: 1.982

7.  Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates.

Authors:  Pumtiwitt C McCarthy; Rina Saksena; Dwight C Peterson; Che-Hung Lee; Yanming An; John F Cipollo; Willie F Vann
Journal:  Glycoconj J       Date:  2013-08-16       Impact factor: 2.916

Review 8.  Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends.

Authors:  Francesca Micoli; Roberto Adamo; Paolo Costantino
Journal:  Molecules       Date:  2018-06-15       Impact factor: 4.411

9.  Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.

Authors:  Mohammad Murshid Alam; Megan Kelly Bufano; Peng Xu; Anuj Kalsy; Y Yu; Y Wu Freeman; Tania Sultana; Md Rasheduzzaman Rashu; Ishaan Desai; Grace Eckhoff; Daniel T Leung; Richelle C Charles; Regina C LaRocque; Jason B Harris; John D Clements; Stephen B Calderwood; Firdausi Qadri; W F Vann; Pavol Kováč; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2014-02-06

10.  Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen.

Authors:  Li Ou; Wing-Pui Kong; Gwo-Yu Chuang; Mridul Ghosh; Krishana Gulla; Sijy O'Dell; Joseph Varriale; Nathan Barefoot; Anita Changela; Cara W Chao; Cheng Cheng; Aliaksandr Druz; Rui Kong; Krisha McKee; Reda Rawi; Edward K Sarfo; Arne Schön; Andrew Shaddeau; Yaroslav Tsybovsky; Raffaello Verardi; Shuishu Wang; Timothy G Wanninger; Kai Xu; Gengcheng J Yang; Baoshan Zhang; Yaqiu Zhang; Tongqing Zhou; Frank J Arnold; Nicole A Doria-Rose; Q Paula Lei; Edward T Ryan; Willie F Vann; John R Mascola; Peter D Kwong
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.